This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant in children under 12 years old with conductive or mixed hearing loss.
Hearing Loss, Conductive, Hearing Loss, Mixed
This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant in children under 12 years old with conductive or mixed hearing loss.
Expanded Indications in the Pediatric BONEBRIDGE Population
-
University of Colorado Health/Children's Hospital of Colorado, Aurora, Colorado, United States, 80045
University of Miami, Miami, Florida, United States, 33136
University Hospital Newark/Rutgers New Jersey Medical School, Newark, New Jersey, United States, 07103
University of North Carolina, Chapel Hill, North Carolina, United States, 27517
The Ohio State University/Nationwide Children's Hospital, Columbus, Ohio, United States, 43210
University of Utah Health/Primary Children's Hospital, Salt Lake City, Utah, United States, 84132
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
3 Years to 12 Years
ALL
No
Med-El Corporation,
2025-08